Factors Influencing Bronchopulmonary Dysplasia: An Eight-Year Study in a Single Tertiary Care Unit in Thailand
DOI:
https://doi.org/10.33192/smj.v77i2.271246Keywords:
Bronchopulmonary dysplasia (BPD), respiratory outcomes, mortality, ThailandAbstract
Objective: To assess the incidence trends of severe BPD or death, identify associated risk factors, and develop a predictive model using Jensen’s BPD grading system.
Materials and Methods: This retrospective study included infants with a gestational age (GA) < 32 weeks born between 2013 and 2020. Infants were classified into no BPD and BPD (all grades) or death categories. Risk factors and a predictive model for outcomes were identified using multivariable logistic regression and evaluated with a receiver operating characteristic (ROC) curve.
Results: Among the 772 infants, 286 (37%) were classified into the BPD group. The incidence of BPD continuously increased from 16.3% in 2013 to 49.4% in 2020. Multivariate analyses revealed factors associated with severe BPD, including IUGR, the 1-minute Apgar score, surfactant administration, late-onset sepsis, hydrocortisone, PDA ligation, postnatal steroid and mechanical ventilation (MV) days. The highest adjusted odds ratio (aOR) was for MV > 42 days at 19.29 (95% CI; 7.22–51.55; p<0.001). The area under the curve (AUC) was 0.898, with 80.68%
sensitivity and 84.83% specificity.
Conclusion: When Jensen’s criteria were used, the incidence and risk factors for severe BPD or death in Thai neonates were similar to those reported in previous studies. The regression model exhibited good predictive value, potentially assisting clinicians in targeted interventions.
References
Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022;327(3):248-63.
Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-56.
Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr. 2018;197:300-8.
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am J Respir Crit Care Med. 2019;200(6):751-9.
Stoecklin B, Simpson SJ, Pillow JJ. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis. Paediatr Respir Rev. 2019;32:91-7.
Li J, Xu H. Comparisons of two definitions of bronchopulmonary dysplasia for the premature infants. Pediatr Pulmonol. 2022;57(1):217-23.
Katz TA, van Kaam AH, Schuit E, Mugie SM, Aarnoudse-Moens CSH, Weber EH, et al. Comparison of New Bronchopulmonary Dysplasia Definitions on Long-Term Outcomes in Preterm Infants. J Pediatr. 2023;253:86-93.e4.
Geetha O, Rajadurai VS, Anand AJ, Dela Puerta R, Huey Quek B, Khoo PC, et al. New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks. J Perinatol. 2021;41(8):1943-50.
Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IA, Watterberg K, et al. Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop. Obstet Gynecol. 2016;127(3):426-36.
Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179-201.
Chronic lung disease: Gestational age < 33 weeks [Internet]. Canadian Neoantal Network. 2022. Available from: https://www.canadianneonatalnetwork.org/portal/Portals/0/Annual%20Reports/2022%20CNN%20Annual%20Report.pdf.
Yang T, Shen Q, Wang S, Dong T, Liang L, Xu F, et al. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study. BMC Pediatr. 2022;22(1):200.
Jensen EA, Edwards EM, Greenberg LT, Soll RF, Ehret DEY, Horbar JD. Severity of Bronchopulmonary Dysplasia Among Very Preterm Infants in the United States. Pediatrics. 2021;148(1):e2020030007.
Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med. 2021;34(11):1721-31.
WHO recommendations on Antenatal corticosteroids for improving preterm birth outcomes [Internet]. World Health Organization. 2021. Available from: https://www.who.int/publications/i/item/9789240057296.
Shen X, Patel N, Zhu W, Chen X, Lu K, Cheng R, et al. A nomogram for predicting the risk of Bronchopulmonary dysplasia in premature infants. Heliyon. 2023;9(8):e18964.
Jassem-Bobowicz JM, Klasa-Mazurkiewicz D, Żawrocki A, Stefańska K, Domżalska-Popadiuk I, Kwiatkowski S, et al. Prediction Model for Bronchopulmonary Dysplasia in Preterm Newborns. Children (Basel). 2021;8(10):886.
Yazici A, Buyuktiryaki M, Simsek GK, Kanmaz Kutman HG, Canpolat FE. Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia. Eur Rev Med Pharmacol Sci. 2022;26(5):1579-85.
Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11(11):CD001456.
Wongkhonkaen C, Paopongsawan P, Jirapradittha J, Kiatchoosakun P. Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome. Siriraj Med J. 2023;75(5):330-42.
Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology. 2023;120(1):3-23.
Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, et al. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019;205:41-8.e6.
Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, Dijkman KP, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N Engl J Med. 2023;388(11):980-90.
Garg A, Athiraman N, Jenkins E, Crossland D, Loganathan PK. Is early patent ductus arteriosus ligation helpful in premature neonates? A 10-year retrospective study. World J Pediatr. 2022;18(5):350-7.
Wang H, Jain A, Weisz DE, Moraes TJ. Trends in patent ductus arteriosus ligation in neonates and changes in outcomes: A 10-year multicenter experience. Pediatr Pulmonol. 2021;56(10):3250-7.
Menshykova AO, Dobryanskyy DO. Duration of mechanical ventilation and clinical outcomes in very low birth weight infants: A single center 10-years cohort study. J Neonatal Perinatal Med. 2023;16(4):673-80.
Published
How to Cite
License
Copyright (c) 2024 Siriraj Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.
